Sangamo BioSciences | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Alaunos Therapeutics USD 1.94M 941K 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
BioCryst Pharmaceuticals USD 84.08M 3.95M 2025-09
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 7.46M 985K 2025-09
CSL USD 2.16B 633M 2025-06
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
J&J USD 18.23B 10.35B 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Pfizer USD 1.34B 295M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Tectonic Therapeutic USD 268.44M 18.94M 2025-09
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09


Sangamo BioSciences Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.